Correlation of Serum Ferritin Levels with Liver Iron Overload on Magnetic Resonance Imaging in Thalassemia Major Patients
Correlation of Serum Ferritin Levels with Liver Iron Overload on Magnetic Resonance Imaging
DOI:
https://doi.org/10.54393/pjhs.v6i7.3285Keywords:
Beta Thalassemia, Iron Overload, Serum Ferritin, T2-weighted MRIAbstract
Blood transfusions are often necessary for people with thalassemia major, which causes iron buildup in critical organs. Objectives: To determine the correlation between Serum Ferritin and MRI-based liver iron levels. Methods: This cross-sectional analytical study was conducted on 101 beta thalassemia major patients visiting Shahida Islam Medical College and Hospital, Lodhran, in-between July 2024 to December 2024 using a non-probability consecutive sampling technique. Patients of Beta thalassemia major older than 15 years and dependent on blood transfusions were included in the study. Patients having any cardiac disease (valvular or congenital) or with any ongoing infection were excluded from the study. Patients who did not follow up regularly and did not consume chelation were also excluded. The association between serum ferritin concentrations and hepatic iron levels measured by T2 MRI was assessed using Spearman’s correlation, with a p-value below 0.05 considered significant. Results: In this study of 101 thalassemia major patients, serum ferritin levels showed a significant negative correlation with liver iron overload measured by MRI (r=-0.25, p=0.03). Moderate hepatic iron overload was the most common finding (41.58%). Serum ferritin and AST levels increased significantly with worsening iron burden, while other liver function parameters showed no significant variation across groups. MRI proved more reliable than serum ferritin alone for assessing hepatic iron load. Conclusions: This study demonstrated a significant correlation between serum ferritin levels and hepatic iron overload evaluated through T2-weighted MRI in thalassemia major patients.
References
Shafique F, Ali S, Almansouri T, Van Eeden F, Shafi N, Khalid M, et al. Thalassemia, a Human Blood Disorder. Brazilian Journal of Biology. 2021 Sep; 83: e246062. doi: 10.1590/1519-6984.246062.
Aksu T and Unal S. Thalassemia. Trends in Pediatrics. 2021 Mar; 2(1): 1-7. doi: 10.5222/TP.2021.10820.
Meri MA, Al-Hakeem AH, Al-Abeadi RS. An Overview of Thalassemia: A Review Article. Medical Sciences Journal of Advanced Research. 2022 Mar; 3(1): 26-32. doi: 10.46966/msjar.v3i1.36.
Ali S, Mumtaz S, Shakir HA, Khan M, Tahir HM, Mumtaz S, et al. Current Status of Beta-Thalassemia and Its Treatment Strategies. Molecular Genetics and Genomic Medicine. 2021 Dec; 9(12): e1788. doi: 10.1002/mgg3.1788.
Kontoghiorghes GJ. Iron Load Toxicity in Medicine: From Molecular and Cellular Aspects to Clinical Implications. International Journal of Molecular Sciences. 2023 Aug; 24(16): 12928. doi: 10.3390/ijms241612928.
Sadiq IZ, Abubakar FS, Usman HS, Abdullahi AD, Ibrahim B, Kastayal BS, et al. Thalassemia: Pathophysiology, Diagnosis, and Advances in Treatment. Thalassemia Reports. 2024 Oct; 14(4): 81-102. doi: 10.3390/thalassrep14040010.
Yadav PK and Singh AK. A Review of Iron Overload in Beta-Thalassemia Major, and a Discussion on Alternative Potent Iron Chelation Targets. Plasmatology. 2022 May; 16: 26348535221103560. doi: 10.1177/26348535221103560.
Kwiatkowski JL. Clinical Challenges with Iron Chelation in Beta Thalassemia. Hematology/Oncology Clinics of North America. 2023 Apr; 37(2): 379-391. doi: 10.1016/j.hoc.2022.12.013.
Bruzzese A, Martino EA, Mendicino F, Lucia E, Olivito V, Bova C, et al. Iron Chelation Therapy. European Journal of Haematology. 2023 May; 110(5): 490-497. doi: 10.1111/ejh.13935.
Spasiano A, Meloni A, Costantini S, Quaia E, Cademartiri F, Cinque P, et al. Setting for "Normal" Serum Ferritin Levels in Patients with Transfusion-Dependent Thalassemia: Our Current Strategy. Journal of Clinical Medicine. 2021 Dec; 10(24): 5985. doi: 10.3390/jcm10245985.
Atmakusuma TD and Lubis AM. Correlation of Serum Ferritin and Liver Iron Concentration with Transient Liver Elastography in Adult Thalassemia Intermedia Patients with Blood Transfusion. Journal of Blood Medicine. 2021 Apr; 12: 235-243. doi: 10.2147/JBM.S303703.
Pinyopornpanish K, Tantiworawit A, Leerapun A, Soontornpun A, Thongsawat S. Secondary Iron Overload and the Liver: A Comprehensive Review. Journal of Clinical and Translational Hepatology. 2023 Feb; 11(4): 932.
Sohal A and Kowdley KV. A Review of New Concepts in Iron Overload. Gastroenterology and Hepatology. 2024 Feb; 20(2): 98.
Pecorelli A, Franceschi P, Braccischi L, Izzo F, Renzulli M, Golfieri R. MRI Appearance of Focal Lesions in Liver Iron Overload. Diagnostics. 2022 Apr; 12(4): 891. doi: 10.3390/diagnostics12040891.
Kurban LA, Almarri BK, Alshamsi MH, Abdelrahman SS, Alwahshi SG, Alhorani Q, et al. Optimized Serum Ferritin Prediction of Iron Overload in Transfusion-Dependent Thalassemia: Likelihood Ratio and Age-Adjustment Approach. Annals of Saudi Medicine. 2023 Mar; 43(2): 90-96. doi: 10.5144/0256-4947.2023.90.
Reeder SB, Yokoo T, França M, Hernando D, Alberich-Bayarri Á, Alústiza JM, et al. Quantification of Liver Iron Overload with MRI: Review and Guidelines from the ESGAR and SAR. Radiology. 2023 Feb; 307(1): e221856. doi: 10.1148/radiol.221856.
El-Shanshory MR, Sherief LM, Hassab HM, Ragab SM, Yahia S, Mansour AK, et al. Prevalence of Iron Deficiency Anemia and Beta Thalassemia Carriers among Relatives of Beta Thalassemia Patients in Nile Delta Region, Egypt: A Multicenter Study. Journal of the Egyptian Public Health Association. 2021 Oct; 96(1): 1-8. doi: 10.1186/s42506-021-00088-9.
Henninger B, Alustiza J, Garbowski M, Gandon Y. Practical Guide to Quantification of Hepatic Iron with MRI. European Radiology. 2020 Jan; 30 (1): 383-393. doi: 10.1007/s00330-019-06380-9.
Khaliq S. Thalassemia in Pakistan. Hemoglobin. 2022 Jan; 46(1): 12-14. doi: 10.1080/03630269.2022.2059670.
Ning X, Peng F, Tan S, Tang C, Luo C, Xiao F, et al. Quantitative MRI Evaluation of Iron Deposition in Patients with Transfusion-Dependent Thalassemia: Clinical Management Insights. Expert Review of Hematology. 2024 Dec; 17(12): 977-983. doi: 10.1080/17474086.2024.2435353.
Meloni A, Positano V, Ricchi P, Pepe A, Cau R. What Is the Importance of Monitoring Iron Levels in Different Organs over Time with Magnetic Resonance Imaging in Transfusion-Dependent Thalassemia Patients? Expert Review of Hematology. 2025 Apr; 18(4): 291-299. doi: 10.1080/17474086.2025.2486379.
Voskaridou E, Douskou M, Terpos E, Papassotiriou I, Stamoulakatou A, Ourailidis A, et al. Magnetic Resonance Imaging in the Evaluation of Iron Overload in Patients with Beta Thalassemia and Sickle Cell Disease. British Journal of Haematology. 2004 Sep; 126(5): 736-742. doi: 10.1111/j.1365-2141.2004.05104.x.
Fischer R, Longo F, Nielsen P, Engelhardt R, Hider RC, Piga A. Monitoring Long-Term Efficacy of Iron Chelation Therapy by Deferiprone and Desferrioxamine in Patients with Beta-Thalassemia Major: Application of SQUID Biomagnetic Liver Susceptometry. British Journal of Haematology. 2003 Jun; 121(6): 938-948. doi: 10.1046/j.1365-2141.2003.04297.x.
Xu F, Peng Y, Xie H, Liang B, Yang G, Zhao F, et al. A Multicenter Study on the Quantification of Liver Iron Concentration in Thalassemia Patients by Means of the MRI T2* Technique. Frontiers in Medicine. 2023 May; 10: 1180614. doi: 10.3389/fmed.2023.1180614.
Shah F, Huey K, Deshpande S, Turner M, Chitnis M, Schiller E, et al. Relationship between Serum Ferritin and Outcomes in Beta-Thalassemia: A Systematic Literature Review. Journal of Clinical Medicine. 2022 Jul; 11(15): 4448. doi: 10.3390/jcm11154448.
Mohammad II and Al-Doski FS. Assessment of Liver Functions in Thalassemia. Tikrit Journal of Pharmaceutical Sciences. 2012; 8(1): 87-95. doi: 10.25130/tjphs.2012.8.1.11.87.95.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Pakistan Journal of Health Sciences

This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments